Estie Mermelstein, MSN, FNP-BC

Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.

Investigators conducted a study to determine the optimal fixed-dose combination of rifampicin/isoniazid/pyrazinamide in children with tuberculosis infection.

Investigators conducted a study to assess the efficacy of a cell-based quadrivalent inactivated influenza vaccine (IIV4c) in preventing influenza virus infection in adolescents and children.

Researchers conducted a study to determine the effect of patient characteristics and racial/ethnic disparities on outcomes of SARS-CoV-2 infection.

Investigators assessed the relationship between HIV infection and impaired pulmonary gas exchange, as well as the influence HIV has on the diffusing capacity of the lungs for carbon monoxide in patients with and without comorbid chronic obstructive pulmonary disease.

Investigators conducted a study to determine whether iota-carrageenan nasal spray decreases the risk for SARS-CoV-2 infection among health care workers managing patients with COVID-19.

Investigators conducted a study to determine the optimal management of drug-resistant cytomegalovirus in 2 patients who previously underwent stem cell and kidney transplantation.

Investigators conducted a study to determine the effects of quinine hydrochloride in combination with antimicrobial blue light therapy in patients with cutaneous mold infection.

Investigators conducted a study to determine the effects of antiretroviral therapy on weight gain in patients with HIV infection.

Investigators conducted a secondary analysis that assessed virologic outcomes following 48 weeks of first-line treatment with dolutegravir/lamivudine in patients with newly diagnosed HIV infection.

Researchers sough to assess the effects of treatment with a monoclonal antibody infusion in patients hospitalized with COVID-19.

Researchers sought to assess the safety, tolerability, and immunogenicity of a novel pneumococcal conjugate vaccine (V114) in patients at risk for pneumococcal disease.

Investigators conducted a systemic review to assess the effects of various medications on seroconversion rates following SARS-CoV-2 vaccination in patients with immune mediated inflammatory disease.

Investigators sought to identify factors associated with septic shock development and 30-day mortality in patients admitted to an intensive care unit for treatment of candidemia.

Investigators conducted a study to determine whether empiric antibiotic therapy with adjunctive gentamicin improves outcomes in patients with septic shock admitted to the intensive care unit.

Investigators conducted a study that compared outcomes between patients with COVID-19 infected with the Alpha, Beta, or Delta variants and those infected with wild-type virus.

Immunity against neuraminidase is important to consider in development of therapeutics and influenza vaccines with improved efficacy and protection.

Investigators conducted a meta-analysis of 3 randomized controlled trials that compared the clinical safety and efficacy of janus kinase inhibitors with placebo or standard care for the treatment of patients with COVID-19.

Investigators conducted a study to determine the relationship between gut microbiota and ghrelin concentrations among patients with positive Helicobacter pylori infection vs those with antigen-negative H pylori infection who received eradication therapy.

In a secondary data analysis, investigators sought to assess potential prescribing disparities for integrase strand transfer inhibitors in patients with HIV infection.

Investigators conducted a multiplatform trial to compare the effects of therapeutic-dose heparin with standard care thromboprophylaxis for the treatment of patients hospitalized with moderate COVID-19.

Investigators compared adverse effects of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines reported in the COVID Symptom Study App with those reported during phase 3 trials.

Investigators conducted a retrospective cohort study to determine the difference in COVID-19 outcomes in patients with HIV infection compared with those without HIV infection.

Researchers assessed the performance of a pneumonia panel in relation to clinical measures and outcome variables.

Study highlights decreased confidence in the human papillomavirus vaccine in the United States.

Investigators conducted a prospective genomic surveillance study of gut-colonizing third-generation cephalosporin-resistant Gram-negative organisms and vancomycin-resistant enterococci to improve infection prevention efforts in high-risk settings.

Researchers examined the expression of IL-21 receptor during HIV-1 infection and its role in HIV-1-specific CD8+ T cell maintenance and subsequent viral control.

As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.

Researchers studied the impact of current opioid agonist therapy on initiation of chronic hepatitis C virus treatment among a population of individuals who inject drugs.

Investigators evaluated resistance to fluoroquinolones, nitrofurantoin, and trimethoprim-sulfamethoxazole in patients with uncomplicated urinary tract infection.